107534-93-0
基本信息
安五酯素
安五脂素对照品
安五脂素标准品
安五脂素, >98%
安五脂素 (安五酯素)
安五脂素, 来源于五味子
ANWULIGAN 安五酯素
Anwuligan
Macelignan
ANWULIGNAN
(+)-Anwulignan
Macelignan, >98%
Anwuligan(Macelignan)
Macelignan >=98% (HPLC)
Anwuligan, 98%, from Schisandra chinensis
4-(2S,3R)-4-(1,3-benzodioxol-5-yl-2-3-dimetybty]-2_methoxyphenol
物理化学性质
| 外观性状 | 白色结晶粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于五味子Schisandra chinensis 的根或皮。 |
| 熔点 | 70-71℃ |
| 沸点 | 467.0±40.0 °C(Predicted) |
| 密度 | 1.159 |
| 闪点 | 236℃ |
| 储存条件 | -20°C储存 |
| 溶解度 | DMSO : ≥ 30 mg/mL (91.35 mM) |
| 酸度系数(pKa) | 10.19±0.20(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色 |
| 化妆品成分功效 | DEODORANT ORAL CARE ANTIMICROBIAL ANTIOXIDANT |
| InChI | 1S/C20H24O4/c1-13(8-15-4-6-17(21)19(10-15)22-3)14(2)9-16-5-7-18-20(11-16)24-12-23-18/h4-7,10-11,13-14,21H,8-9,12H2,1-3H3/t13-,14+/m0/s1 |
| InChIKey | QDDILOVMGWUNGD-UONOGXRCSA-N |
| SMILES | OC1=C(OC)C=C(C[C@H](C)[C@H](C)CC2=CC=C(OCO3)C3=C2)C=C1 |
| LogP | 5.220 (est) |
安全数据
| 危险性符号(GHS) | ![]() GHS07 |
| 警示词 | 警告 |
| 危险性描述 | H302-H315-H319-H335 |
| 防范说明 | P280-P305+P351+P338 |
| WGK Germany | WGK 3 |
| 海关编码 | 29329990 |
| 存储类别 | 11 - Combustible Solids |
安五脂素价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2026/09/15 | HY-N0064 | 安五脂素 Macelignan | 107534-93-0 | 1 mg | 250元 |
| 2026/09/15 | HY-N0064 | 安五脂素 Macelignan | 107534-93-0 | 5mg | 700元 |
| 2026/09/15 | HY-N0064 | 安五脂素 Macelignan | 107534-93-0 | 10mM * 1mLin DMSO | 770元 |
常见问题列表
|
COX-2
|
Macelignan (1-50 μM; 72 hours) does not reduce cell viability alone, however, UVB treatment, even at the lowest dose of 30 mJ/cm 2 , reduces HaCaT cell viability in a dose-dependent mannner,it reduces approximately 80% of control values at 100 μM in hacat cells.Macelignan (0.1-1 μM; 24 hours) decreases COX-2 expression in a concentration-dependent manner,and at the highest concentration of macelignan (1 μM) , COX-2 expression is inhibited by almost 50% in hacat cells.
Cell Viability Assay
| Cell Line: | Hacat cells |
| Concentration: | 1 μM; 2.5 μM; 5 μM; 10 μM; 15 μM; 50 μM |
| Incubation Time: | 72 hours |
| Result: | Induced cell death by UVB irradiation at 30 mJ/cm 2 from 10 μM. |
Western Blot Analysis
| Cell Line: | Hacat cells |
| Concentration: | 0.1 μM; 0.5 μM;1 μM |
| Incubation Time: | 24 hours |
| Result: | Reduced UVB-induced COX-2 expression in cells. |
Macelignan (oral administration; 15 mg/kg; every day for three weeks) exhibits in vivo anti-diabetic effects. The baseline (day 0) fasting blood glucose levels does not differ between groups; at the end of the experiment, the values of the Macelignan-treated group are significantly lower compared to the diabetic control group in C57BL/KsJ- db/db mice.
| Animal Model: | Male C57BL/KsJ- db/db mice |
| Dosage: | 15 mg/kg |
| Administration: | Oral administration; 15 mg/kg; every day for three weeks |
| Result: | Significantly reduced the blood glucose levels in mice. |
